Seroatlas · Human Serome Atlas

LILRB2

Leukocyte immunoglobulin-like receptor subfamily B member 2

Also known as: CD85d, ILT4, LIR-2, LIR2, LIRB2_HUMAN, MIR-10, MIR10

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8N423
Gene
LILRB2
Ensembl
ENSG00000131042
Chromosome
19
Canonical length
597 aa
Protein class
CD markers, Predicted membrane proteins

OverviewNCBI Gene

This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

597 residues, UniProt reviewed canonical sequence.

>Q8N423|LILRB2
     1  MTPIVTVLIC LGLSLGPRTR VQTGTIPKPT LWAEPDSVIT QGSPVTLSCQ GSLEAQEYRL
    61  YREKKSASWI TRIRPELVKN GQFHIPSITW EHTGRYGCQY YSRARWSELS DPLVLVMTGA
   121  YPKPTLSAQP SPVVTSGGRV TLQCESQVAF GGFILCKEGE DEHPQCLNSQ PHARGSSRAI
   181  FSVGPVSPNR RWSHRCYGYD LNSPYVWSSP SDLLELLVPG VSKKPSLSVQ PGPVMAPGES
   241  LTLQCVSDVG YDRFVLYKEG ERDLRQLPGR QPQAGLSQAN FTLGPVSRSY GGQYRCYGAH
   301  NLSSECSAPS DPLDILITGQ IRGTPFISVQ PGPTVASGEN VTLLCQSWRQ FHTFLLTKAG
   361  AADAPLRLRS IHEYPKYQAE FPMSPVTSAH AGTYRCYGSL NSDPYLLSHP SEPLELVVSG
   421  PSMGSSPPPT GPISTPGPED QPLTPTGSDP QSGLGRHLGV VIGILVAVVL LLLLLLLLFL
   481  ILRHRRQGKH WTSTQRKADF QHPAGAVGPE PTDRGLQWRS SPAADAQEEN LYAAVKDTQP
   541  EDGVEMDTRA AASEAPQDVT YAQLHSLTLR RKATEPPPSQ EREPPAEPSI YATLAIH

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against LILRB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.42
Highest tissue expression
49 nTPM

Expression across tissuesHPA

Tissue

  • spleen: 49 nTPM
  • bone marrow: 33 nTPM
  • lung: 14 nTPM
  • appendix: 11 nTPM
  • adipose tissue: 6.2 nTPM
  • blood vessel: 4.7 nTPM

Single-cell type

  • monocytes: 38 nCPM
  • neutrophils: 17 nCPM
  • microglia: 13 nCPM
  • kupffer cells: 10 nCPM
  • macrophages: 8.6 nCPM
  • cdc: 8.5 nCPM

Immune cell

  • non-classical monocyte: 152 nTPM
  • intermediate monocyte: 131 nTPM
  • neutrophil: 63 nTPM
  • classical monocyte: 61 nTPM
  • total PBMC: 30 nTPM
  • myeloid DC: 19 nTPM

Brain region

  • medulla oblongata: 1.7 nTPM
  • thalamus: 1.7 nTPM
  • choroid plexus: 1.2 nTPM
  • cerebral cortex: 1.1 nTPM
  • pons: 1.1 nTPM
  • white matter: 0.5 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.12
gnomAD pLI
0
gnomAD missense Z
-2.3
DepMap mean gene effect
-0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of LILRB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads LILRB2 as an antibody target. Whether an autoantibody or antibody against LILRB2 could matter depends on whether native LILRB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

LILRB2 is annotated at the cell surface, where native LILRB2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label LILRB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/LILRB2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...